Published in Vaccine Weekly, August 12th, 2009
"We show here that the N-terminal transmembrane domain (TMD) of HBV S can be replaced by the TMDs of the hepatitis C virus (HCV) envelope proteins El and E2, to generate fusion proteins containing the entire HCV El or E2 sequence that are efficiently coassembled with the HBV S into particles. This demonstrates the remarkable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly